Achillion shares up; FDA lifts hold on hepatitis C drug
June 10, 2014 at 10:25 AM EDT
News comes a day after Merck said it is buying Idenix, another company developing HCV drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.